Canine Atopic Dermatitis Market - By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others), By Mode Of Administration (Topical, Oral, Injectable), By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce), And By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 203
Status: Published
Report Code: ARI100417
According to the American College of Veterinary Dermatology (ACVD) report, around 10% to 15% of dogs suffered from this canine atopic dermatitis in 2017. The x of this disease is not completely understood yet, though genetic abnormalities are reported to be one of the major reasons behind it. According to a study by the American Journal of Veterinary Research, the risk to develop canine atopic dermatitis in golden retrievers was around 50% in the U.K. due to geographic variation, which is expected to bolster the revenue in the coming years.
The increasing number of veterinary practitioners is one of the major factors driving the demand for this market. According to the American Veterinary Medical Association, a total of 113,394 veterinary practitioners were present in the U.S. in 2018 compared to 110,531 in 2017. Moreover, increasing number of veterinary hospitals and clinics is propelling the market growth.
Furthermore, increasing R&D investment by the key industry players, product launches, and strong drug pipeline are also expected to contribute significantly to the market growth. For instance, Kindred Biosciences, Inc. reportedly has 4 monoclonal antibodies in their pipeline for canine atopic dermatitis, which is expected to launch in the coming five years. In 2016, Zoetis launched Cytopoint, a monoclonal antibody which became a blockbuster drug in 2018.
The rising demand for pet insurance and increasing concern among pet owners are anticipated to exhibit a positive impact on the market in the coming years. Moreover, stringent regulations by the Food and Drug Administration (FDA) and other regulatory bodies in order to reduce the off-label usage of human drugs in animals is boosting the market growth. Key players in the market include Elanco, Virbac, and Toray Industries.
Analyst Commentary
On the basis of product, the canine atopic dermatitis treatment market is segmented into glucocorticoids, antihistamines, immunosuppressants, MAbs, and others. Glucocorticoids dominated the market in terms of revenue in 2020, owing to its increased usage and cheaper cost. Topical and oral glucocorticoids were found to be the first line of treatment for the management of canine atopic dermatitis. Oral prednisone, prednisolone, and methylprednisolone are usually preferred for the treatment of acute flares. The side effects are also minimal as compared to other dosage forms.
The Monoclonal Antibodies (MAbs) segment is expected to show lucrative growth over the forecast period. This treatment therapy is comparatively new and found to be very effective. Zoetis launched its first MAb in 2016, which is administered to the patients every four to eight weeks and is claimed to reduce itching immediately. There are more MAbs currently under clinical trials and are expected to show positive results in the coming years.
On the basis of mode of administration, the canine atopic dermatitis market is segmented into oral, topical, and injectable. The oral segment held the largest revenue share in 2020 owing to its lesser price. Moreover, it is more convenient as compared to injectable and topical modes. The dog owners can administer the drugs by themselves which is further fueling its demand.
The injectable segment is expected to show lucrative growth over the forecast period owing to its efficacy and potency. Rapid onset of action can be seen in the case of injectable, which is expected to propel the demand in the near future. Currently, veterinarians are prescribing a combination of oral and injectable therapy for better results. Growth of the injectable segment will be fuelled by the presence of an extensive product pipeline.
On the basis of mode of administration, the canine atopic dermatitis market is segmented into oral, topical, and injectable. The oral segment held the largest revenue share in 2020 owing to its lesser price. Moreover, it is more convenient as compared to injectable and topical modes. The dog owners can administer the drugs by themselves which is further fuelling its demand.
The injectable segment is expected to show lucrative growth over the forecast period owing to its efficacy and potency. Rapid onset of action can be seen in the case of injectable, which is expected to propel the demand in the near future. Currently, veterinarians are prescribing a combination of oral and injectable therapy for better results. Growth of the injectable segment will be fuelled by the presence of an extensive product pipeline.
By the distribution channel, the canine atopic dermatitis treatment market is segmented into veterinary hospitals/clinics, retail, and e-commerce. The retail segment dominated the market in 2020 owing to increased product availability. The advent of retail pharmacy chains is a major contributor to the share of the distribution channel segment. Adoption of digitalized systems in retail pharmacies to reduce risk of errors in the prescriptions is anticipated to propel the revenue growth over the coming years. Moreover, veterinarians have begun to rely on general pharmacies to fill prescriptions for drugs, which are not available in vet pharmacies, which is further propelling the market growth.
By the distribution channel, the canine atopic dermatitis treatment market is segmented into veterinary hospitals/clinics, retail, and e-commerce. The retail segment dominated the market in 2020 owing to increased product availability. The advent of retail pharmacy chains is a major contributor to the share of the distribution channel segment. Adoption of digitalized systems in retail pharmacies to reduce risk of errors in the prescriptions is anticipated to propel the revenue growth over the coming years. Moreover, veterinarians have begun to rely on general pharmacies to fill prescriptions for drugs, which are not available in vet pharmacies, which is further propelling the market growth.
Segmentation
The Canine Atopic Dermatitis Market is segmented on the basis of product, mode of administration, distribution channel, and region. On the basis of Product, the global market is segmented into Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others. On the basis of mode of administration, the global market is bifurcated into Topical, Oral, Injectable. On the basis of distribution channel Veterinary Hospitals/Clinics, Retail, E-commerce.
Regional Analysis
North America dominated the regional market in 2020 and is anticipated to witness the same trend over the forecast period. This growth can be attributed to the increasing incidence of canine atopic dermatitis in pet dogs, new product launches, and growing concern among pet owners. The rising pet ownership is further boosting the market growth. Furthermore, there is high investment in the development of new drugs by major players, which is expected to propel the growth over the forecast period.
Latin America held a substantial share owing to the presence of a large number of pet dogs in this region. Brazil and Argentina are among the top 10 countries having the highest number of pets in the world. Asia Pacific region is expected to show lucrative growth over the forecast period. The growing disposable income increases the probability of higher adoption of companion animals, which is further expanding the future growth prospects. Continual up-gradation of healthcare infrastructure is also presumed to present the market with high potential growth opportunities over the forecast period.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Functionalitys
2.3.1. Secondary Functionalitys
2.3.1.1. Preliminary data mining
2.3.2. Primary Functionalitys
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Global Canine Atopic Dermatitis Market
Chapter 5. Global Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
5.1. Global Canine Atopic Dermatitis Market Share, By Functionality, 2015 - 2027 (USD Million)
5.1.1. Glucocorticoids
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Antihistamines
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Immunosuppressants
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.4. Others
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
6.1. Global Canine Atopic Dermatitis Share, By Mode of Administration, 2015 - 2027 (USD Million)
6.1.1. Topical
6.1.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Oral
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Injectable
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
7.1. Global Canine Atopic Dermatitis Share, By Distribution Channel, 2015 - 2027 (USD Million)
7.1.1. Veterinary Hospitals/Clinics
7.1.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Retail
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.3. E-Commerce
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.4. Others
7.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Canine Atopic Dermatitis Market Overview, By Geography, 2015 – 2027 (USD Million)
8.1. Global Canine Atopic Dermatitis Market Share, By Geography, 2015 - 2027 (USD Million)
8.1.1. Market Size and projections, by Countries, 2015 – 2027 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2019 (%)
Chapter 9. North America Canine Atopic Dermatitis Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1. North America Global Canine Atopic Dermatitis Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.2. North America Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
9.1.3. North America Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
9.1.4. North America Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
9.1.5. North America Canine Atopic Dermatitis Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.5.1. U.S. Canine Atopic Dermatitis Market Overview, 2015 - 2027 (USD Million)
9.1.5.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.5.1.2. U.S. Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
9.1.5.1.3. U.S. Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
9.1.5.1.4. U.S. Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
9.1.5.2. Canada Canine Atopic Dermatitis Market Overview, 2015 - 2027 (USD Million)
9.1.5.2.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.5.2.2. Canada Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
9.1.5.2.3. Canada Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
9.1.5.2.4. Canada Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
9.1.5.3. Mexico Canine Atopic Dermatitis Market Overview, 2015 - 2027 (USD Million)
9.1.5.3.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.5.3.2. Mexico Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
9.1.5.3.3. Mexico Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
9.1.5.3.4. Mexico Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
Chapter 10. Europe Canine Atopic Dermatitis Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Europe Canine Atopic Dermatitis Market Overview, 2015 – 2027 (USD Million)
10.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.2. Europe Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
10.1.3. Europe Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
10.1.4. Europe Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
10.1.5. Europe Canine Atopic Dermatitis Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.5.1.2. Germany Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
10.1.5.1.3. Germany Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
10.1.5.1.4. Germany Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
10.1.5.2. France
10.1.5.2.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.5.2.2. France Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
10.1.5.2.3. France Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
10.1.5.2.4. France Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
10.1.5.3. UK
10.1.5.3.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.5.3.2. UK Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
10.1.5.3.3. UK Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
10.1.5.3.4. UK Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
10.1.5.4. Italy
10.1.5.4.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.5.4.2. Italy Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
10.1.5.4.3. Italy Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
10.1.5.4.4. Italy Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
10.1.5.5. Spain
10.1.5.5.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.5.5.2. Spain Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
10.1.5.5.3. Spain Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
10.1.5.5.4. Spain Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
10.1.5.6. Rest of Europe
10.1.5.6.1. Market size and projections, 2015 – 2025
10.1.5.6.2. Rest of Europe Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
10.1.5.6.3. Rest of Europe Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
10.1.5.6.4. Rest of Europe Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
Chapter 11. Asia Pacific Canine Atopic Dermatitis Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Asia Pacific Canine Atopic Dermatitis Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.2. Asia Pacific Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
11.1.3. Asia Pacific Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
11.1.4. Asia Pacific Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
11.1.5. Asia Pacific Canine Atopic Dermatitis Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.5.1.2. India Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
11.1.5.1.3. India Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
11.1.5.1.4. India Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
11.1.5.2. China
11.1.5.2.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.5.2.2. China Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
11.1.5.2.3. China Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
11.1.5.2.4. China Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
11.1.5.3. Japan
11.1.5.3.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.5.3.2. Japan Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
11.1.5.3.3. Japan Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
11.1.5.3.4. Japan Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
11.1.5.4. South Korea
11.1.5.4.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.5.4.2. South Korea Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
11.1.5.4.3. South Korea Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
11.1.5.4.4. South Korea Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
11.1.5.5.3. Rest of Asia Pacific Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
11.1.5.5.4. Rest of Asia Pacific Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
Chapter 12. Middle East & Africa Global Canine Atopic Dermatitis Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. Middle East & Africa Canine Atopic Dermatitis Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.2. Middle East & Africa Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
12.1.3. Middle East & Africa Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
12.1.4. Middle East & Africa Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
12.1.5. Middle East & Africa Canine Atopic Dermatitis Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.5.1.2. GCC Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
12.1.5.1.3. GCC Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
12.1.5.1.4. GCC Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
12.1.5.2. South Africa
12.1.5.2.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.5.2.2. South Africa Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
12.1.5.2.3. South Africa Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
12.1.5.2.4. South Africa Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
12.1.5.3.4. Rest of Middle East & Africa Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
Chapter 13. South America Global Canine Atopic Dermatitis Market Overview, By Countries, 2015 - 2027 (USD Million)
13.1. South America Canine Atopic Dermatitis Market Overview, 2015 - 2027 (USD Million)
13.1.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.2. South America Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
13.1.3. South America Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
13.1.4. South America Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
13.1.5. South America Canine Atopic Dermatitis Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.5.1. Brazil
13.1.5.1.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.5.1.2. Brazil Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
13.1.5.1.3. Brazil Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
13.1.5.1.4. Brazil Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
13.1.5.2. Argentina
13.1.5.2.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.5.2.2. Argentina Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
13.1.5.2.3. Argentina Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
13.1.5.2.4. Argentina Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
13.1.5.3. Rest of South America
13.1.5.3.1. Market size and projections, 2015 – 2026
13.1.5.3.2. Rest of South America Canine Atopic Dermatitis Market Overview, By Functionality, 2015 - 2027 (USD Million)
13.1.5.3.3. Rest of South America Canine Atopic Dermatitis Market Overview, By Mode of Administration, 2015 - 2027 (USD Million)
13.1.5.3.4. Rest of South America Canine Atopic Dermatitis Market Overview, By Distribution Channel, 2015 - 2027 (USD Million)
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Functionality & Topical
Chapter 15. Key Player Analysis
15.1. Elanco
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Functionality & Topical Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Virbac
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Functionality & Topical Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Toray Industries
Chapter 16. Global Canine Atopic Dermatitis Market Cost Analysis
16.1. Global Canine Atopic Dermatitis Market Key Raw Functionality Analysis
16.1.1. Key Raw Functionality
16.1.2. NEUROLOGY Trend of Key Raw Functionality
16.1.3. Key Suppliers of Raw Functionality
16.1.4. Market Concentration Rate of Raw Functionality
16.2. Proportion of Wing Cost Structure
16.2.1. Raw Functionality
16.2.2. Labor Cost
16.2.3. Wing Expenses
16.3. Wing Process Analysis of Unsaturated Polyester Resin (UPR) for Composites
Chapter 17. Chain, Sourcing Strategy and Downstream Buyers
17.1. Global Canine Atopic Dermatitis Market Chain Analysis
17.2. Upstream Raw Functionality Sourcing
17.3. Raw Functionality of Global Canine Atopic Dermatitis Market Major Manufacturers in 2019
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Electrical Damage
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Functionality & Topical Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Functionality & Topical Progress in Related Functionality
19.2. Topical Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Canine Atopic Dermatitis Market share, by Functionality, 2020 & 2027 (%)
10. Global Canine Atopic Dermatitis Market share, by Glucocorticoids, by Functionality, 2020 & 2027 (USD Million)
11. Global Canine Atopic Dermatitis Market share, by Antihistamines, by Functionality, 2020 & 2027 (USD Million)
12. Global Canine Atopic Dermatitis Market share, by Immunosuppressants, by Functionality, 2020 & 2027 (USD Million)
13. Global Canine Atopic Dermatitis Market share, by Others, by Functionality, 2020 & 2027 (USD Million)
14. Global Canine Atopic Dermatitis Market share, by Mode of Administration, 2020 & 2027 (%)
15. Global Canine Atopic Dermatitis Market share, by Tropical, by Mode of Administration, 2020 & 2027 (USD Million)
16. Global Canine Atopic Dermatitis Market share, by Oral, by Mode of Administration, 2020 & 2027 (USD Million)
17. Global Canine Atopic Dermatitis Market share, by Injectable, by Mode of Administration, 2020 & 2027 (USD Million)
18. Global Canine Atopic Dermatitis Market share, by Distribution Channel, 2020 & 2027 (%)
19. Global Canine Atopic Dermatitis Market share, by Veterinary Hospitals/Clinics, by Distribution Channel, 2020 & 2027 (USD Million)
20. Global Canine Atopic Dermatitis Market share, by Retail, by Distribution Channel, 2020 & 2027 (USD Million)
21. Global Canine Atopic Dermatitis Market share, by region, 2020 - 2027(%)
22. Global Canine Atopic Dermatitis Market share, by region, 2019 - 2027(USD Million)
23. North America Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
24. North America Global Canine Atopic Dermatitis Market share, by Countries, 2020 & 2027 (%)
25. U.S. Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
26. Canada Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
27. Europe Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
28. Europe Global Canine Atopic Dermatitis Market share, by Countries, 2020 & 2027 (%)
29. Spain Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
30. UK Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
31. Italy Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
32. Germany Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
33. France Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
34. Rest of Europe Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
35. Asia-Pacific Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
36. Asia-Pacific Global Canine Atopic Dermatitis Market share, by Countries, 2020 & 2027 (%)
37. China Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
38. India Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
39. Australia Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
40. Japan Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
41. Rest of Asia-Pacific Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
42. Middle East & Africa Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
43. Middle East & Africa Global Canine Atopic Dermatitis Market share, by Countries, 2020 & 2027 (%)
44. GCC Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
45. South Africa Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
46. Rest of Middle East & Africa Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
47. South America Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
48. Brazil Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
49. Mexico Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
50. Argentina Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
51. Rest Of South America Global Canine Atopic Dermatitis Market, 2020 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Canine Atopic Dermatitis Market, 2020-2027 (USD Million)
4. Canine Atopic Dermatitis requirement, by country, 2020-2027, (USD Million)
5. North America Canine Atopic Dermatitis Market, By Functionality, 2020-2027 (USD Million)
6. North America Canine Atopic Dermatitis Market, by Mode of Administration, 2020-2027 (USD Million)
7. North America Canine Atopic Dermatitis Market, by Functionality, 2020-2027 (USD Million)
8. Europe Canine Atopic Dermatitis Market, By Functionality, 2020-2027 (USD Million)
9. Europe Canine Atopic Dermatitis Market, by Mode of Administration, 2020-2027 (USD Million)
10. Europe Canine Atopic Dermatitis Market, by Functionality, 2020-2027 (USD Million)
11. Asia Pacific Canine Atopic Dermatitis Market, By Functionality, 2020-2027 (USD Million)
12. Asia Pacific Canine Atopic Dermatitis Market, by Mode of Administration, 2020-2027 (USD Million)
13. Asia Pacific Canine Atopic Dermatitis Market, by Functionality, 2020-2027 (USD Million)
14. Middle East & Africa Global Canine Atopic Dermatitis Market, By Functionality, 2020-2027 (USD Million)
15. Middle East & Africa Canine Atopic Dermatitis Market, by Mode of Administration, 2020-2027 (USD Million)
16. Middle East & Africa Canine Atopic Dermatitis Market, by Functionality, 2020-2027 (USD Million)
17. South America Canine Atopic Dermatitis Market, By Functionality, 2020-2027 (USD Million)
18. South America Canine Atopic Dermatitis Market, by Mode of Administration, 2020-2027 (USD Million)
19. South America Canine Atopic Dermatitis Market, by Functionality, 2020-2027 (USD Million)
20. Global Canine Atopic Dermatitis Market, Company Market Share, 2018 (%)
21. Elanco: Product Benchmarking
22. Virbac: Financial Performance
23. Toray Industries: Product Benchmarking
The Leading Key Players in Canine Atopic Dermatitis Market
Elanco
Virbac
Toray Industries.
